Telome Health Inc. launched Tuesday to provide data from tissue samples for academic research, pharmaceutical drug development and health monitoring.
Menlo Park-based Telome Health said it leverages the predictive power of data related to telomeres, the protective caps at the ends of chromosomes, to assess health status, disease and mortality risk, and responses to specific therapies.
No comments:
Post a Comment